Companies / BOC Sciences / Anifrolumab
BOC Sciences

Anifrolumab | BOC Sciences

Anifrolumab is a monoclonal antibody that blocks the activity of type I interferon (IFN). Anifrolumab has been investigated for the treatment of systemic lupus erythematosus (SLE).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More